Raporty Spółek ESPI/EBI

Supplement to announcements under Art. 89t of the LPOS regarding the initial public offering of an issue of warrants with an exercise period of up to 3, 5 and 7 years, respectively SOPHARMA AD (BG11SOSOBT18)

09-01-2026 15:37:17 | ESPI | 12/2026
oUNI-EN: Supplement to announcements under Art. 89t of the LPOS regarding the initial public offering of an issue of warrants with an exercise period of up to 3, 5 and 7 years, respectively

 PAP
Data: 2026-01-09
Firma: SOPHARMA AD
oSpis tresci:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

oSpis zalacznikow:
Znaleziono 1 załącznik
  • SFA_89t_ad_w_09012026_espi.pdf
    		•  Arkusz: REPORT

    Nazwa arkusza: REPORT


    POLISH FINANCIAL SUPERVISION AUTHORITY
    UNI - EN REPORT No 12 / 2026
    Date of issue: 2026-01-09
    Short name of the issuer
    SOPHARMA AD
    Subject
    Supplement to announcements under Art. 89t of the LPOS regarding the initial public offering of an issue of warrants with an exercise period of up to 3, 5 and 7 years, respectively
    Official market - legal basis
    Art. 56. 1. 2 of Act on Public Offering
    Unofficial market - legal basis
    Contents of the report:
    Sofia, Bulgaria, January 9, 2026 - "Sopharma" AD, with its registered office and registered office in Sofia, 16 Iliensko Shose Str., UIC831902088, supplements the announcements under art. 89t of the LPOS regarding the initial public offering of an issue of warrants with an exercise period of up to 3, 5 and 7 years, respectively, published on January 9, 2026 with current reports ą 6, ą 8 and ą 10 as follows:
    "The rights are issued in favor of the shareholders, entered as such in the register of "Central Depository" AD no later than 5 business days after the date of publication of the announcement under Art. 89t, para. 1 of the LPOS on the website of the Issuer and on the website of the Investment Intermediary "Sofia International Securities" AD.
    The current shareholders acquire the rights free of charge. All other investors may purchase rights through a transaction on the main market organized by the "Bulgarian Stock Exchange" AD, a rights segment during the period for transferring the rights or at the public auction organized by the "Bulgarian Stock Exchange" AD for the unexercised rights, after the expiration of the period for transferring the rights."
    Annexes
    File Description
    SFA_89t_ad_w_09012026_espi.pdf Supplement to announcements under Art. 89t of the LPOS regarding the initial public offering of an issue of warrants with an exercise period of up to 3, 5 and 7 years, respectively

    Nazwa arkusza: INFORMATION ABOUT THE ENTITY


    SOPHARMA AD
    _fullname of the issuer_
    SOPHARMA AD Farmaceutyczny _far_
    _short name of the issuer_ _sector according to clasification
    of the WSE in Warsow_
    1220 Sofia
    _post code_ _city_
    IlienskoShosse 16
    _street_ _number_
    +359 2 813 42 00 +359 2 936 02 86
    _phone number_ _fax_
    _e-mail_ _web site_
    nd
    _NIP_ _REGON_

    Nazwa arkusza: SIGNATURE OF PERSONS REPRESENTING THE COMPANY


    SIGNATURE OF PERSONS REPRESENTING THE COMPANY
    Date Name Position / Function Signature
    2026-01-09 Ognian Ivanov Donev Executive Director


    Identyfikator raportu jjvuszwyf1
    Nazwa raportu UNI-EN
    Symbol raportu UNI-EN
    Nazwa emitenta SOPHARMA AD
    Symbol Emitenta SOPHARMA AD
    Tytul Supplement to announcements under Art. 89t of the LPOS regarding the initial public offering of an issue of warrants with an exercise period of up to 3, 5 and 7 years, respectively
    Sektor Farmaceutyczny (far)
    Kod 1220
    Miasto Sofia
    Ulica IlienskoShosse
    Nr 16
    Tel. +359 2 813 42 00
    Fax +359 2 936 02 86
    e-mail
    NIP nd
    REGON
    Data sporzadzenia
    Rok biezacy 2026
    Numer 12
    adres www
    Serwis Ekonomiczny Polskiej Agencji Prasowej SA 2026 Copyright PAP SA - Wszelkie prawa zastrzezone.